Real-World Outcomes of Brexanolone to Treat Postpartum Depression

Given the shared mechanism of action between brexanolone and the recently approved oral medication for PPD, zuranolone, the applicability of findings and relevance to the more accessible oral drug, zuranolone, are explored.

Authors

Institutions

Publication Details

Journal
Women s Health Reports
Published
2025-04-01
DOI
https://doi.org/10.1177/26884844251383702
Citations
1
Primary Topic
Maternal Mental Health During Pregnancy and Postpartum
Type
article
Field-Weighted Citation Impact
1.88
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Real-World Outcomes of Brexanolone to Treat Postpartum Depression

Jennifer E. Hettema, Samuel T. Wilkinson, Melissa Barrett, Constance Youngman et al.
1 citations
Women s Health Reports
Maternal Mental Health During Pregnancy and Postpartum
1.88
article

Real-World Outcomes of Brexanolone to Treat Postpartum Depression

Jennifer E. Hettema, Samuel T. Wilkinson, Melissa Barrett, Constance Youngman, Rachel Dalthorp
article en
1 citations

Abstract

Given the shared mechanism of action between brexanolone and the recently approved oral medication for PPD, zuranolone, the applicability of findings and relevance to the more accessible oral drug, zuranolone, are explored.

Women s Health ReportsVol. 6(1)
Yale University (US), Scottsdale Research Institute (United States) (US)
Openalex Percentile: Top 12%
Maternal Mental Health During Pregnancy and Postpartum
1.88
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.